Skip to main content
. Author manuscript; available in PMC: 2017 Jan 15.
Published in final edited form as: Int J Cancer. 2015 Aug 17;138(2):417–427. doi: 10.1002/ijc.29709

Figure 4.

Figure 4

Invasion of engineered B16F10 MCC: Reduced invasion of CD146-silenced MCC to craniofacial, appendicular structures and liver (compared to NT-shRNA), evaluated by BLI (a) and gross examination (b and c). BLI signal reached statistical significance (* = p < 0.01). Data are represented as mean ± SEM. Representative mice of n = 6 (3 per group).